DDIS-25. PENTAMIDINE; A NEW CHEMOTHERAPY TARGETING ON GLIOMA STEM LIKE CELLS

INTRODUCTION: Glioblastoma (GBM) is the most common primary malignant brain tumors. Despite aggressive therapies, median overall survival of patients who suffered from GBM is only 18 months. Furthermore, there is no effective therapy for glioma stem cells (GSCs), which act as forming tumors. Herein,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Tamai, Sho, Jiapaer, Shabierjiang, Zhang, Guangtao, Zhang, Jiakang, Wang, Yi, Sabit, Hemragul, Tanaka, Shingo, Kinoshita, Masashi, Hirao, Atsushi, Nakada, Mitsutoshi
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2019
Materias:
Drug Discovery
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847863/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.276
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares